John De Shazo Net Worth

Insiders trading at ProPhase Labs Inc

Over the last 15 years, insiders at ProPhase Labs Inc have traded over $6,868,501 worth of ProPhase Labs Inc stock and bought 2,996,691 units worth $4,189,802 . The most active insiders traders include Braden Michael Leonard, Ted William Karkus oraz James T Mccubbin. On average, ProPhase Labs Inc executives and independent directors trade stock every 98 days with the average trade being worth of $586,896. The most recent stock trade was executed by Ted William Karkus on 1 February 2023, trading 500,000 units of PRPH stock currently worth $300,000.

What does ProPhase Labs Inc do?

prophase labs is a diversified natural health medical science company. for more information visit us at www.prophaselabs.com.

ProPhase Labs Inc executives and stock owners

ProPhase Labs Inc executives and other stock owners filed with the SEC include:

• Ted William Karkus,
  Chairman & CEO
• Monica Brady,
  Chief Financial Officer
• Ted Karkus,
  Chairman of the Board, Chief Executive Officer
• Monica Brady,
  Chief Financial Officer
• Warren Hirsch,
  Independent Director
• Louis Gleckel,
  Independent Director
• Jason Barr,
  Independent Director
• Sergio Miralles,
  Exec. VP & Chief Information Officer of ProPhase Diagnostics
• Sam A. Beeler,
  Chief Strategy Officer of Precision Medicine
• Jason Karkus,
  Exec. VP & Co-COO
• Alice Lioi,
  Exec. VP & Co-COO
• Mark S Leventhal,
  Director
• Mark Shawn Frank,
  Director
• James T Mccubbin,
  Director
• Mark A. Burnett,
  Director
• Braden Michael Leonard,
  10% owner
• Guy J Quigley,
  10% owner
• Robert V Jr Cuddihy,
  Chief Operating Officer
• John De Shazo,
  Director
• Jed Latkin,
  Director
• Robert A. Jr. Morse,
  CHIEF FINANCIAL OFFICER